Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce M Robinson

Showing results (61-70 of 206) with videos related to

Pageof 21
Sort By:
Kidney International|June 18, 2018
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patientsAngelo Karaboyas, Hairong Xu, Hal Morgenstern, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2019
Variability in Cinacalcet Prescription across US Hemodialysis FacilitiesDouglas S Fuller, Shan Xing, Vasily Belozeroff, et al.
Kidney International Reports|January 11, 2021
Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and MortalityAngelo Karaboyas, Friedrich K Port, Ziad A Massy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2025
New Index Demonstrates Association between Social Vulnerability, Environmental Burden, and Kidney Failure Risk among Individuals with Glomerular DiseaseLoryn W Dass, Abigail R Smith, Jill Krissberg, et al.
Kidney International|January 8, 2010
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapyVolker Wizemann, Lin Tong, Sudtida Satayathum, et al.
Nephron. Clinical Practice|August 18, 2010
C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Takehiko Kawaguchi, Lin Tong, Bruce M Robinson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2011
C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patientsJonathan Bazeley, Brian Bieber, Yun Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns StudyJeffrey Perl, Jinyao Zhang, Brenda Gillespie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 18, 2023
Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPSHirotaka Komaba, Junhui Zhao, Angelo Karaboyas, et al.
Kidney360|April 4, 2022
Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns StudyPablo Ureña-Torres, Brian Bieber, Fitsum Guebre-Egziabher, et al.
Pageof 21

Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Kidney International|June 18, 2018
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patientsAngelo Karaboyas, Hairong Xu, Hal Morgenstern, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2019
Variability in Cinacalcet Prescription across US Hemodialysis FacilitiesDouglas S Fuller, Shan Xing, Vasily Belozeroff, et al.
Kidney International Reports|January 11, 2021
Long- Versus Short-Acting Erythropoiesis-Stimulating Agent Type and MortalityAngelo Karaboyas, Friedrich K Port, Ziad A Massy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2025
New Index Demonstrates Association between Social Vulnerability, Environmental Burden, and Kidney Failure Risk among Individuals with Glomerular DiseaseLoryn W Dass, Abigail R Smith, Jill Krissberg, et al.
Kidney International|January 8, 2010
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapyVolker Wizemann, Lin Tong, Sudtida Satayathum, et al.
Nephron. Clinical Practice|August 18, 2010
C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Takehiko Kawaguchi, Lin Tong, Bruce M Robinson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2011
C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patientsJonathan Bazeley, Brian Bieber, Yun Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns StudyJeffrey Perl, Jinyao Zhang, Brenda Gillespie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 18, 2023
Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPSHirotaka Komaba, Junhui Zhao, Angelo Karaboyas, et al.
Kidney360|April 4, 2022
Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns StudyPablo Ureña-Torres, Brian Bieber, Fitsum Guebre-Egziabher, et al.
Pageof 21